abstract |
The present invention relates to methods of selecting, screening, engineering, manufacturing, and modifying antibodies that have improved bioavailability when administered to humans by subcutaneous administration. The invention also describes antibodies and variant antibodies having improved bioavailability when administered to humans by subcutaneous administration. |